XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 29, 2024
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the six month period ended June 29, 2024 was as follows:

 

   Shares   Weighted
Average Grant
Fair Value
 
Balance, December 30, 2023   1,931,767   $1.65 
Granted   4,131,820    1.31 
Forfeited   (328,100)   2.70 
Vested   (246,459)   2.00 
Balance, June 29, 2024   5,489,028    1.32 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and six months ended June 29, 2024 and July 1, 2023 (no tax benefits were recognized):

  

   Three Months
Ended
   Three Months
Ended
   Six months
ended
   Six months
ended
 
   June 29, 2024   July 1, 2023   June 29, 2024   July 1, 2023 
Cost of product revenues  $268,318   $427,323   $488,924   $453,541 
Research and development   117,086    322,294    260,909    339,168 
Selling, general and administrative   291,014    441,641    661,513    592,740 
Total  $676,418   $1,191,258   $1,411,346   $1,385,449